Similar Papers

Paper Title
Journal
Date
Author
AB0487 HCQ COULD ACT ON SLE PATIENTS THROUGH THE MODULATING EXPRESSION OF IL-8 ALONG WITH S100 PROTEINS
Risa Wakiya ... Hiromi Shimada
-
Risa Wakiya, et. al.Risa Wakiya ... Hiromi Shimada
01 Jun 2019
AB0527 S100 proteins are novel biomarkers for the efficacy of hcq treatment to skin lesion in systemic lupus erythematosus
R Wakiya ... K Ueeda
Annals of the Rheumatic Diseases | VOL. 77
R Wakiya, et. al.R Wakiya ... K Ueeda
01 Jun 2018
Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
Risa Wakiya ... Shusaku Nakashima
Clinical Rheumatology | VOL. 41
Risa Wakiya, et. al.Risa Wakiya ... Shusaku Nakashima
18 Jul 2022
POS0121 ASSOCIATION OF LUPUS LOW DISEASE ACTIVITY STATE ATTAINMENT WITH REDUCED ORGAN DAMAGE AND FLARE IN SLE PATIENTS WITH HIGH DISEASE ACTIVITY
...
Annals of the Rheumatic Diseases | VOL. 81
, et. al. ...
23 May 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.